DK2976101T3 - Behandlingsfremgangsmåde - Google Patents

Behandlingsfremgangsmåde Download PDF

Info

Publication number
DK2976101T3
DK2976101T3 DK14711232.0T DK14711232T DK2976101T3 DK 2976101 T3 DK2976101 T3 DK 2976101T3 DK 14711232 T DK14711232 T DK 14711232T DK 2976101 T3 DK2976101 T3 DK 2976101T3
Authority
DK
Denmark
Prior art keywords
treatment procedure
procedure
treatment
Prior art date
Application number
DK14711232.0T
Other languages
English (en)
Inventor
Yaela Baine
Jacqueline Miller
Original Assignee
Glaxosmithkline Biologicals Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50336313&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2976101(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxosmithkline Biologicals Sa filed Critical Glaxosmithkline Biologicals Sa
Application granted granted Critical
Publication of DK2976101T3 publication Critical patent/DK2976101T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Virology (AREA)
DK14711232.0T 2013-03-18 2014-03-17 Behandlingsfremgangsmåde DK2976101T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361802918P 2013-03-18 2013-03-18
US201361874008P 2013-09-05 2013-09-05
PCT/EP2014/055355 WO2014147044A1 (en) 2013-03-18 2014-03-17 Method of treatment

Publications (1)

Publication Number Publication Date
DK2976101T3 true DK2976101T3 (da) 2020-11-23

Family

ID=50336313

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14711232.0T DK2976101T3 (da) 2013-03-18 2014-03-17 Behandlingsfremgangsmåde

Country Status (21)

Country Link
US (1) US11883478B2 (da)
EP (1) EP2976101B1 (da)
JP (2) JP6747968B2 (da)
KR (1) KR20150121265A (da)
CN (1) CN105188743A (da)
AU (1) AU2014234408B2 (da)
BE (1) BE1021934B1 (da)
BR (1) BR112015024014A2 (da)
CA (1) CA2903322C (da)
CY (1) CY1123600T1 (da)
DK (1) DK2976101T3 (da)
EA (1) EA034380B1 (da)
ES (1) ES2830035T3 (da)
HU (1) HUE051592T2 (da)
IL (1) IL241096B (da)
MX (1) MX382165B (da)
PL (1) PL2976101T3 (da)
PT (1) PT2976101T (da)
SG (2) SG11201506810RA (da)
SI (1) SI2976101T1 (da)
WO (1) WO2014147044A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109890413B (zh) 2016-09-02 2024-04-16 赛诺菲巴斯德股份有限公司 脑膜炎奈瑟氏菌疫苗
WO2019084632A1 (en) * 2017-11-06 2019-05-09 The Crown in right of the State of New South Wales acting through the Department of Primary Industries as an office of the Department of Industry Vaccine
CN110652585B (zh) * 2018-10-26 2023-05-26 武汉博沃生物科技有限公司 多糖-蛋白缀合物免疫制剂及其制备与应用
BR112022008761A2 (pt) * 2019-11-22 2022-07-26 Glaxosmithkline Biologicals Sa Dosagem e administração de uma vacina de glicoconjugado de sacarídeo

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7018637B2 (en) 1998-02-23 2006-03-28 Aventis Pasteur, Inc Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines
CA2435681C (en) * 2001-01-23 2011-06-21 Aventis Pasteur Multivalent meningococcal polysaccharide-protein conjugate vaccine
GB0409745D0 (en) * 2004-04-30 2004-06-09 Chiron Srl Compositions including unconjugated carrier proteins
AU2012203419B2 (en) * 2005-06-27 2014-06-26 Glaxosmithkline Biologicals S.A. Immunogenic composition
HUE045482T2 (hu) 2005-06-27 2019-12-30 Glaxosmithkline Biologicals Sa Immunogén készítmény
WO2007071786A2 (en) * 2005-12-23 2007-06-28 Glaxosmithkline Biologicals Sa Conjugate vaccines
NZ572054A (en) 2006-03-22 2011-12-22 Novartis Ag Regimens for immunisation with meningococcal conjugates

Also Published As

Publication number Publication date
SI2976101T1 (sl) 2021-01-29
PT2976101T (pt) 2020-11-12
US20160279225A1 (en) 2016-09-29
IL241096A0 (en) 2015-11-30
WO2014147044A1 (en) 2014-09-25
IL241096B (en) 2021-05-31
AU2014234408A1 (en) 2015-10-22
CN105188743A (zh) 2015-12-23
PL2976101T3 (pl) 2021-03-08
CY1123600T1 (el) 2022-03-24
EP2976101B1 (en) 2020-08-19
BE1021934B1 (fr) 2016-01-27
HUE051592T2 (hu) 2021-03-01
EA034380B1 (ru) 2020-01-31
MX382165B (es) 2025-03-13
CA2903322C (en) 2023-09-05
EA201591468A1 (ru) 2016-04-29
CA2903322A1 (en) 2014-09-25
US11883478B2 (en) 2024-01-30
AU2014234408B2 (en) 2017-04-20
JP2019142898A (ja) 2019-08-29
ES2830035T3 (es) 2021-06-02
SG11201506810RA (en) 2015-10-29
JP2016515539A (ja) 2016-05-30
BR112015024014A2 (pt) 2017-07-18
MX2015013401A (es) 2016-01-08
KR20150121265A (ko) 2015-10-28
JP6747968B2 (ja) 2020-08-26
EP2976101A1 (en) 2016-01-27
SG10201710137QA (en) 2018-01-30

Similar Documents

Publication Publication Date Title
NL301252I2 (nl) tislelizumab
NL301165I2 (nl) diroximelfumaraat
IL268987B (en) System for glaucoma treatment
IL240388A0 (en) Methods of treating melanoma
EP3620203C0 (en) VASCULAR TREATMENT DEVICES
PL3623002T3 (pl) Cewnik
EP2968894A4 (en) MEDICAL CONNECTOR
EP3821931C0 (en) ORONASAL PATIENT INTERFACE
EP2922514A4 (en) BI-RADIAL PATIENT INTERFACE
IL243082B (en) Surgical suit
EP2967969C0 (en) IMPLANT
DK3052081T3 (da) Pastil
LT3007726T (lt) Tautopatijos gydymo būdai
DK3060460T3 (da) Saddel
DK2956698T3 (da) Bindestrimler
DK3027598T3 (da) Oxoquinazolinyl-butanamidderivater
EP2982331A4 (en) Treatment tool
PL2991633T3 (pl) Terapia bakteriofagami
DK2946640T3 (da) Langmuir-probe
DE102013106534B8 (de) Chromatographiepipettenspitze
DK3068314T3 (da) Årepresse
BR302014001196S1 (pt) Configuração aplicada em dispositivo médico
EP2839068A4 (en) Clothes treatment apparatus
HRP20181307T1 (hr) Postupak izrade zubne proteze
DK3089778T3 (da) Ballonkateter